Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeoAsia Pte. Ltd.

neoasia.com.sg

Latest From NeoAsia Pte. Ltd.

Device/Diagnostics Quarterly Deal Statistics, Q2 2015

At $1.8 billion, Q2 device financing nearly doubled the Q1 total, mainly from an increase in IPOs and early VC rounds, and acquisitions were slightly higher at $4.7 billion. Diagnostics funding also increased to $784 million from Q1's $597 million, and Danaher's monster $13.8 billion buy of life sciences company Pall headlined the second quarter's $15.6 billion total in diagnostics M&A activity.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Southeast Asia
        • Singapore
  • Parent & Subsidiaries
  • NeoAsia Pte. Ltd.
  • Senior Management
  • Jimmy Ang, Managing Dir.
  • Contact Info
  • NeoAsia Pte. Ltd.
    Phone: 6552 7787
    6 Tagore Dr. #04-07
    Tagore Bldg.
    , 787623
    Singapore
Advertisement
Advertisement
UsernamePublicRestriction

Register